secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sunshine Biopharma Inc. (SBFM)
CIK:        0001402328
Form:       8-K
Filed at:   2021-11-03T23:59:59+00:00
Accession:  0001683168-21-005210
Event type: leadership
Sentiment:  positive
Materiality: 0.55
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sunshine Biopharma expands board to 5, adds 3 independent directors, aims for Nasdaq uplist
--------------------------------------------------------------------------------

- Board expanded from 3 to 5 members; added Andrew Telsey (legal), JD Kish (accounting), Dr. Rabi Kiderchah (medical).
- Camille Sebaaly resigned as director but remains CFO.
- New appointments part of Company's application process to uplist to Nasdaq.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1402328/000168316821005210/0001683168-21-005210-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1402328/000168316821005210/sunshine_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-21-005210

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer